SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-119249
Filing Date
2020-04-24
Accepted
2020-04-24 17:09:24
Documents
3
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 S-8 d919005ds8.htm S-8 69705
2 EX-5.1 d919005dex51.htm EX-5.1 4134
3 EX-23.1 d919005dex231.htm EX-23.1 1351
  Complete submission text file 0001193125-20-119249.txt   76223
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237840 | Film No.: 20815984
SIC: 2834 Pharmaceutical Preparations